Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Urinary JCV-DNA Testing during Natalizumab Treatment May Increase Accuracy of PML Risk Stratification.
CD8+ T-Cell Deficiency, Epstein-Barr Virus Infection, Vitamin D Deficiency, and Steps to Autoimmunity: A Unifying Hypothesis.
Center for Drug Evaluation and Research Approval Letter, application number: 21-897
White matter volume is decreased in the brain of patients with neuromyelitis optica.
Acorda Announces Initiation of Phase 3 Clinical Trial for Dalfampridine in Post-Stroke Walking Deficits
Epstein-Barr virus latent membrane protein 2A exacerbates experimental autoimmune encephalomyelitis and enhances antigen presentation function.
Ipilimumab Therapy in Patients With Advanced Melanoma and Preexisting Autoimmune Disorders.
Remote effects of intermittent theta burst stimulation of the human pharyngeal motor system.
Comparing routine neurorehabilitation program with trunk exercises based on Bobath concept in multiple sclerosis: Pilot study.
MRI in multiple sclerosis: an intra-individual, randomized and multicentric comparison of gadobutrol with gadoterate meglumine at 3 T.
Presumptive Progressive Multifocal Leukoencephalopathy in Multiple Sclerosis after Natalizumab Therapy.
No quiet surrender: molecular guardians in multiple sclerosis brain.
Immunological Hallmarks of JC Virus Replication in Multiple Sclerosis Patients on Long-Term Natalizumab.
HyperCKemia Related to the Initial and Recurrent Attacks of Neuromyelitis Optica.
Progressive multifocal leukoencephalopathy: new concepts.
ATX-MS-1467 in Patients With Relapsing Forms of Multiple Sclerosis
Epstein-Barr virus, latitude and multiple sclerosis.
Reproducibility of Resting State Connectivity in Patients with Stable Multiple Sclerosis.
MULTIPLE SCLEROSIS: MOLECULAR MECHANISMS AND THERAPEUTIC OPPORTUNITIES.
Intraventricularly injected Olig2-NSCs attenuate established relapsing-remitting EAE in mice.
Personalized Medicine in Neurodegenerative Diseases: How Far Away?
Neurorehabilitation for other neurologic disorders.
Naltrexone prescribing information
Early intervention with gene-modified mesenchymal stem cells overexpressing interleukin-4 enhances anti-inflammatory responses and functional recovery in experimental autoimmune demyelination.
Enhanced Axonal Metabolism during Early Natalizumab Treatment in Relapsing-Remitting Multiple Sclerosis.

Pages